• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

formulary

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp store in Las Vegas Nevada on February 7 2024
Pharma

CVS will cover Eli Lilly obesity products Zepbound and Foundayo

CVS will restore coverage to obesity products from Eli Lilly, allowing patients to gain access to the drugs through their existing insurance.
Kevin Dunleavy May 28, 2026 11:20am
China flag against blue sky

China unveils 19 meds picked for new private insurance formulary

Dec 8, 2025 4:45pm
Wegovy

Novo's Wegovy secures preferred obesity spot on CVS formulary

May 1, 2025 2:39pm
Indivior cut its sales forecast after Suboxone marketing indictment

Indivior signs $600M deal to settle opioid marketing accusations

Jul 27, 2020 12:23pm
Roche

UnitedHealthcare backs Amgen biosims over Roche's oncology meds

Aug 16, 2019 10:55am
fighting

Novo’s oral semaglutide could disrupt diabetes coverage: analyst

Mar 5, 2019 12:05pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings